Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

Activation of the interferon signaling pathway is associated with resistance to CDK4/6 inhibitors and immune checkpoint activation in ER-positive breast cancer.

Auteurs : de Angelis C, Fu X, Cataldo ML, Nardone A, Pereira R, Veeraraghavan J, Nanda S, Qin L, Sethunath V, Wang T, Hilsenbeck SG, Benelli M, Migliaccio I, Malorni L, Litchfield LM, Liu J, Donaldson J, Selenica P, Brown DN, Weigelt B, Reis-Filho JS, Park BH, Hurvitz SA, Slamon DJ, Rimawi MF, Jansen VM, Jeselsohn R, Osborne CK, Schiff R
Jaar : 2021
Journal : Clin Cancer Res

Role of imaging for diagnosis and management of aortic valve papillary fibroelastoma and cardiac amyloid light chain amyloidosis: a case report.

Auteurs : Dimov I, Meuleman N, de Cannière D, Unger P
Jaar : 2021
Journal : Eur Heart J Case Rep
Volume : 5
Pagina's : ytab322

Peritoneal patch in vascular reconstruction during pancreaticoduodenectomy for pancreatic cancer: a single centre experience.

Auteurs : De Pauw V, Pezzullo M, Bali MA, El Moussaoui I, Racu ML, DHaene N, Bouchart C, Closset J, Van Laethem JL, Navez J
Jaar : 2021
Journal : Acta Chir Belg
Pagina's : 1-22

Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature.

Auteurs : Mjaess G, Karam A, Aoun F, Albisinni S, Roumeguère T
Jaar : 2021
Journal : Cancer

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Auteurs : Strauss SJ, Frezza AM, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brennan B, Brodowicz T, Buonadonna A, De Álava E, Tos APD, Del Muro XG, Dufresne A, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Gaspar N, Gasperoni S, Gelderblom H, Gouin F, Grignani G, Gronchi A, Haas R, Hassan AB, Hecker-Nolting S, Hindi N, Hohenberger P, Joensuu H, Jones RL, Jungels C, Jutte P, Kager L, Kasper B, Kawai A, Kopeckova K, Krákorová DA, Le Cesne A, Le Grange F, Legius E, Leithner A, Pousa AL, Martin-Broto J, Merimsky O, Messiou C, Miah AB, Mir O, Montemurro M, Morland B, Morosi C, Palmerini E, Pantaleo MA, Piana R, Piperno-Neumann S, Reichardt P, Rutkowski P, Safwat AA, Sangalli C, Sbaraglia M, Scheipl S, Schöffski P, Sleijfer S, Strauss D, Hall KS, Trama A, Unk M, Van De Sande MAJ, van der Graaf WTA, van Houdt WJ, Frebourg T, Ladenstein R, Casali PG, Stacchiotti S
Jaar : 2021
Journal : Ann Oncol

A plain language summary of the ASCENT study: Sacituzumab Govitecan for metastatic triple-negative breast cancer.

Auteurs : Bardia A, Hurvitz SA, Rugo HS, Brufsky A, Cortes J, Loibl S, Piccart-Gebhart M, Cowden J, Spears P, Carey LA
Jaar : 2021
Journal : Future Oncol

The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings.

Auteurs : Merimi M, El-Majzoub R, Lagneaux L, Moussa Agha D, Bouhtit F, Meuleman N, Fahmi H, Lewalle P, Fayyad-Kazan M, Najar M
Jaar : 2021
Journal : Front Cell Dev Biol
Volume : 9
Pagina's : 661532

Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective.

Auteurs : Soosaipillai G, Wu A, Dettorre GM, Diamantis N, Chester J, Moss C, Aguilar-Company J, Bower M, Sng CC, Salazar R, Brunet J, Jones E, Mesia R, Jackson A, Mukherjee U, Sita-Lumsden A, Seguí E, Ottaviani D, Carbó A, Benafif S, Würstlein R, Carmona C, Chopra N, Cruz CA, Swallow J, Saoudi N, Felip E, Galazi M, Garcia-Fructuoso I, Lee AJX, Newsom-Davis T, Wong YNS, Sureda A, Maluquer C, Ruiz-Camps I, Cabirta A, Prat A, Loizidou A, Gennari A, Ferrante D, Tabernero J, Russell B, Van Hemelrijck M, Dolly S, Hulbert-Williams NJ, Pinato DJ
Jaar : 2021
Journal : Ther Adv Med Oncol
Volume : 13
Pagina's : 17588359211042224

Myths, Superstitions, and Popular Beliefs: Do They Still Impact Our Practice?

Auteurs : Mjaess G, Aoun F, Kazzi H, Karam A, Albisinni S, Roumeguère T
Jaar : 2021
Journal : Ann Surg

Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study.

Auteurs : Tremblay G, Daniele P, Breeze J, Li L, Shah J, Shacham S, Kauffman M, Engelhardt M, Chari A, Nooka A, Vogl D, Gavriatopoulou M, Dimopoulos MA, Richardson P, Biran N, Siegel D, Vlummens P, Doyen C, Facon T, Mohty M, Meuleman N, Levy M, Costa L, Hoffman JE, Delforge M, Kaminetzky D, Weisel K, Raab M, Dingli D, Tuchman S, Laurent F, Vij R, Schiller G, Moreau P, Richter J, Schreder M, Podar K, Parker T, Cornell RF, Lionel K, Choquet S, Sundar J
Jaar : 2021
Journal : BMC Cancer
Volume : 21
Pagina's : 993

Alpha-smooth muscle actin expression in the stroma predicts resistance to trastuzumab in patients with early-stage HER2-positive breast cancer.

Auteurs : Vathiotis IA, Moutafi MK, Divakar P, Aung TN, Qing T, Fernandez A, Yaghoobi V, El-Abed S, Wang Y, Guillaume S, Nuciforo P, Huober J, Di Cosimo S, Kim SB, Harbeck N, Gomez H, Shafi S, Syrigos KN, Fountzilas G, Sotiriou C, Pusztai L, Warren S, Rimm DL
Jaar : 2021
Journal : Clin Cancer Res

Increase in urolithiasis prevalence due to vitamins C and D supplementation during the COVID-19 pandemic.

Auteurs : Karam A, Mjaess G, Younes H, Aoun F
Jaar : 2021
Journal : J Public Health (Oxf)

Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions.

Auteurs : Thouvenin J, Martinez Chanza N, Alhalabi O, Lang H, Tannir NM, Barthélémy P, Malouf GG
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.

Auteurs : Casasnovas RO, Follows G, Zijlstra JM, Vermaat JSP, Kalakonda N, Choquet S, Neste EVD, Hill B, Thieblemont C, Cavallo F, la Cruz F, Kuruvilla J, Hamad N, Jaeger U, Caimi PF, Gurion R, Warzocha K, Bakhshi S, Sancho JM, Schuster M, Egyed M, Offner F, Vassilakopoulos TP, Samal P, Ku M, Ma X, Chamoun K, Shah J, Canales M, Maerevoet M, Shacham S, Kauffman MG, Goy A
Jaar : 2021
Journal : Clin Lymphoma Myeloma Leuk

Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer.

Auteurs : Schettini F, Giuliano M, Lambertini M, Bartsch R, Pinato DJ, Onesti CE, Harbeck N, Lüftner D, Rottey S, van Dam PA, Zaman K, Mustacchi G, Gligorov J, Awada A, Campone M, Wildiers H, Gennari A, Tjan-Heijnen VCG, Cortes J, Locci M, Paris I, Del Mastro L, De Placido S, Martín M, Jerusalem G, Venturini S, Curigliano G, Generali D
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Prediction of an imminent fracture after an index fracture - Models derived from the Frisbee cohort.

Auteurs : Iconaru L, Charles A, Baleanu F, Surquin M, Benoit F, Mugisha A, Moreau M, Paesmans M, Karmali R, Rubinstein M, Rozenberg S, Body JJ, Bergmann P
Jaar : 2021
Journal : J Bone Miner Res

Intestinal presentation of non-Hodgkin lymphoma: Case report.

Auteurs : Kansoun A, Chamma L, Sadek M, Maerevoet M, Ghorra C, Abboud AA, Alam H
Jaar : 2021
Journal : Int J Surg Case Rep
Volume : 86
Pagina's : 106346

Hepatosplenic T-cell lymphoma: treatment challenges.

Auteurs : Bron D, de Leval L, Michiels S, Wittnebel S
Jaar : 2021
Journal : Curr Opin Oncol
Volume : 33
Pagina's : 406-411

Retrospective validation of coverage probability based simultaneous integrated nodal boost in locally advanced cervical cancer: a mono-institutional analysis.

Auteurs : Kedves A, Gulyban A, Glavak C, Toller G, Völgyi Z, Faour A, Bálint A, Petrási B, Rák T, Lakosi F
Jaar : 2021
Journal : 0
Pagina's : 1-4

Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology.

Auteurs : Castelo-Branco L, Awada A, Pentheroudakis G, Perez-Gracia JL, Mateo J, Curigliano G, Banerjee S, Giuliani R, Lordick F, Cervantes A, Tabernero J, Peters S
Jaar : 2021
Journal : ESMO Open
Volume : 6
Pagina's : 100237